| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8778397 | European Urology | 2018 | 9 Pages |
Abstract
Men with clinically localized (stage I) testicular cancer have an excellent prognosis, regardless of management. Non-risk-adapted active surveillance is an attractive management option where only patients destined to relapse will receive any treatment following orchiectomy. However, individual patient preferences should be discussed in selecting a management strategy.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Phillip Martin Pierorazio, Peter Albers, Peter C. Black, Torgrim Tandstad, Axel Heidenreich, Nicola Nicolai, Craig Nichols,